Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meloxicam vs Diclofenac or Nimesulide in Acute Pharyngitis
NCT02229747Phase 4Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Aug 2001
- Primary completion
- Feb 2002
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, open-label trial of meloxicam in pharyngitis, pharyngotonsillitis and laryngitis (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Change in spontaneous pharyngeal pain at 5 days, Change in pharyngeal pain on deglutition (dysphagia) at 5 days and 3 more. Started Aug 2001; status: completed.
02
Drugs
meloxicam
03
Conditions
pharyngitispharyngotonsillitislaryngitis
Beyond the preview
Go deeper on NCT02229747.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02229747.